PHILADELPHIA, Aug. 20 /PRNewswire/ -- Peer-reviewed safety and efficacy data on Electrical Twitch Obtaining Intramuscular Stimulation (eToims(R)), successfully applied to patients suffering from treatment-resistant chronic pain appeared in the August/September issue of Electromyography and Clinical Neurophysiology. The findings reported by University of Pennsylvania associated physicians Jennifer Chu, M.D. and Ira Schwartz, M.D., Ph.D., represent an important advancement in understanding this debilitating disease.
"Seventy-six million Americans, including Olympic athletes suffer from constant long-standing muscle pain, for which treatment is elusive", says Dr. Chu, Associate Professor of Physical Medicine and Rehabilitation, and faculty at the University of Pennsylvania's Medical School for over 30 years. "This study demonstrates a ground-breaking, non-invasive and drug-free approach that controls and may ultimately eliminate the most common cause of muscle pain".
eToims(R)-related neuromuscular pain research began in 1990, combining 5,000-year-old art of acupuncture with modern technology applied to anatomical and neurophysiological science. In 2006, eToims(R) became non-invasive replacing needle use with a handheld electrical wand. eToims(R) produces muscle twitches by stimulating deep neuromuscular junctions at multiple body areas relieving muscle tightness, differentiating it from all other invasive and noninvasive neuromuscular stimulation.
The results were from 92 patients aged 20 to 82 years, with long standing, treatment non-responsive muscle pain, who paid for ongoing eToims(R) treatments. Pain relief was more definitive in those receiving 3Hz frequency electrical stimulation for 4 seconds than 1Hz for 1 second, establishing the therapeutic importance of low-frequency repetitive stimulation. There were no noted complications or adverse effects from weekly or bi-weekly treatments applied over 18 months.
|SOURCE eToims Medical Technology|
Copyright©2008 PR Newswire.
All rights reserved